1Jongh FE, Janssen HL, de Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 1992 Nov, 103(5) : 1630-1635.
2Liaw YF, Sung JJY, Chow WC, et al. Lamivudine for Patients with Chronie Hepatitis B and Advanced Liver Disease. N Engl J Med,2004,351:1521-1531,.
3Shamliyan TA, MacDonald R, Shaukat A, et al. Antiviral Therapy for Adults with Chronic Hepatitis B:A Systematic Review for a National Institutes of Health Consensus Development Conference. Ann Intern Med, 2009, 150:111 -124.
4Kapoor D, Guptan RC, Wakil SM, et al. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol, 2000, 33:308 -312.
5Tseng PI., Lu SN, Tung HD, et al. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. J Viral Hepatitis, 2005, 12:386- 392.
6Kim SU, Han KH, Nam CM et al. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control aseites. J Gastroenterol Hepatol, 2008, 23 : 1722 -1727.
8Keeffe EB, Dieterieh DT, Han SB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 Update. Clin Gastroenterol Hepatol, 2008, 6: 1315-1341.
9European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B. J Hepatol, 2009, 50:227-242.
3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
3European Association for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B.J Hepatol,2009,50.227-242.
4Keeffe EB,Dieterich DT,Han SB,et al.A treatment algorithm for the management pf chronic hepatitis B virus infection in the United States:2008 Update.Chn Gastroenterol,2008,6:1315-1341.
5Keeffe EB, Dieterich DT,Han SB,et al.A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:2008 Update.Clin Gastroenterol,2008,6:1315-1341.
6European Association for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B. J Hepatol, 2009,50.227-242.
7European Association for the study of the Live. EASL cl- inical practice guidelines: management of chronic hepati- tis B virus infection [J]. J Hepatol , 2012,57 ( 1 ) : 167.
9Lange CM, Bojunga J, Hofmann WP, et al. Severe lactic acidosis during treatment of chronic hepatitis B with ente- cavir in patients with impaired liver function[J]. Hepatolo- gy, 2009,50(6):2 001.
10Hadziyarmis S,Tassopoulos N,Chang TF, et al .Three year study of adefovir dipivoxil(ADV )demonstrates sustained efficacy in pres- umed preeore muta chronic hepatitis B patients in a long-term safety and eficacy study[J].Hepatology,2004,40(1): 17.
